Nandita Shangari is a GentiBio Board Director and Managing Director at RA Capital. Prior to joining RA Capital, she was a Managing Director with Novartis Venture Fund (NVF), a life science investment firm, and held various positions at Novartis in Business Development and Licensing and as a key member of the Kymriah® Global Program Team, helping to bring this novel cell therapy to market. Nandita has also held strategic and group head roles in the Novartis Preclinical Investigative Toxicology organization. She received a BSc in Biochemistry and a PhD in Pharmaceutical Sciences from the University of Toronto, Canada.
Nandita Shangari, PhD
Managing Director RA Capital, Board Director